Toshiaki Iba Selected Research

Disseminated Intravascular Coagulation

1/2022	Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines.
12/2021	Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics.
11/2021	Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment.
6/2021	Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.
3/2021	COVID-19 coagulopathy: is it disseminated intravascular coagulation?
2/2021	Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.
1/2021	Proposal of the Definition for COVID-19-Associated Coagulopathy.
1/2021	Recent advances in the research and management of sepsis-associated DIC.
7/2020	Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.
2/2020	Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiaki Iba Research Topics

Disease

82	Sepsis (Septicemia) 06/2022 - 11/2002
56	Disseminated Intravascular Coagulation 01/2022 - 06/2003
27	Thrombosis (Thrombus) 01/2022 - 01/2005
19	Hemorrhage 01/2022 - 06/2003
17	Septic Shock (Toxic Shock Syndrome) 01/2022 - 12/2011
13	COVID-19 02/2022 - 01/2020
12	Inflammation (Inflammations) 06/2022 - 11/2007
11	Infections 02/2022 - 01/2005
8	Thrombocytopenia (Thrombopenia) 01/2022 - 10/2007
8	Neoplasms (Cancer) 01/2020 - 06/2003
6	Critical Illness (Critically Ill) 07/2021 - 01/2005
4	Shock 06/2022 - 12/2011
4	Venous Thromboembolism 01/2020 - 07/2016
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019 - 11/2007
4	Endotoxemia 01/2017 - 09/2003
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 11/2009
3	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2019
3	Multiple Organ Failure (MODS) 02/2021 - 03/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2003
3	Wounds and Injuries (Trauma) 03/2016 - 12/2008
3	Body Weight (Weight, Body) 05/2015 - 12/2003
2	Dyspnea (Shortness of Breath) 01/2022 - 09/2013
2	Thromboembolism 01/2022 - 01/2020
2	Pain (Aches) 01/2022 - 05/2012
2	Vasculitis (Vasculitides) 12/2020 - 01/2020
2	Thrombotic Microangiopathies 02/2020 - 01/2018
2	Hemophilia A (Haemophilia) 01/2020 - 01/2019
2	Thrombotic Thrombocytopenic Purpura 01/2019 - 01/2018
2	Hemolytic-Uremic Syndrome 01/2019 - 01/2018
2	Pneumonia (Pneumonitis) 05/2012 - 07/2006
1	Vasoplegia 06/2022
1	Heat Stroke (Heatstroke) 02/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Headache (Headaches) 01/2022
1	Pulmonary Embolism 01/2022
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Stroke (Strokes) 01/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2022
1	Hematologic Diseases (Blood Diseases) 02/2021
1	Thrombophilia 12/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Pregnancy Complications 01/2020

Drug/Important Bio-Agent (IBA)

54	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 06/2003
32	AntithrombinsIBA 12/2021 - 11/2002
28	AnticoagulantsIBA 01/2022 - 12/2004
20	ThrombomodulinIBA 02/2022 - 01/2009
9	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 08/2005
8	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022 - 12/2011
8	LipopolysaccharidesIBA 06/2017 - 02/2005
7	Fibrinogen (Factor I)FDA Link 06/2022 - 01/2008
7	Protein CIBA 01/2017 - 12/2004
6	Biomarkers (Surrogate Marker)IBA 02/2022 - 11/2007
5	fibrin fragment D (D-dimer)IBA 06/2022 - 01/2020
5	Histones (Histone)IBA 02/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
4	VaccinesIBA 01/2022 - 07/2021
4	CytokinesIBA 01/2020 - 01/2014
3	Platelet Factor 4IBA 06/2022 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 02/2022 - 01/2015
3	Hemostatics (Antihemorrhagics)IBA 12/2021 - 01/2005
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2019 - 11/2009
3	Factor Xa InhibitorsIBA 07/2016 - 10/2013
3	Fondaparinux (Arixtra)FDA Link 07/2016 - 01/2012
3	danaparoid (Orgaran)FDA Link 01/2008 - 06/2003
2	C-Type Lectins (C-Type Lectin)IBA 02/2022 - 06/2021
2	EndotoxinsIBA 12/2020 - 11/2018
2	CathelicidinsIBA 10/2020 - 02/2016
2	FibrinIBA 01/2020 - 06/2003
2	Complement System Proteins (Complement)IBA 01/2019 - 01/2018
2	Fibrin Fibrinogen Degradation ProductsIBA 09/2017 - 01/2008
2	HMGB1 Protein (HMG1)IBA 06/2017 - 01/2013
2	Antithrombin IIIIBA 07/2016 - 06/2003
2	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 01/2013
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2014 - 01/2014
2	SteroidsIBA 11/2012 - 05/2012
2	Cilostazol (Pletal)FDA LinkGeneric 02/2008 - 11/2006
1	von Willebrand FactorIBA 06/2022
1	Thromboplastin (Tissue Factor)IBA 06/2022
1	MyoglobinIBA 02/2022
1	EnzymesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Coronavirus Spike GlycoproteinIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 12/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021
1	mRNA VaccinesIBA 07/2021
1	Thrombin FDA Link 01/2021
1	Biological ProductsIBA 01/2020

Therapy/Procedure

31	Therapeutics 12/2021 - 11/2002
9	Critical Care (Surgical Intensive Care) 08/2021 - 01/2008
7	Hemoperfusion 01/2022 - 12/2011
5	Punctures 10/2020 - 11/2009
3	Ligation 10/2020 - 01/2016
3	Intravenous Infusions 07/2014 - 12/2011
2	Drug Therapy (Chemotherapy) 10/2004 - 12/2003